Great science doesn’t happen in isolation. It happens when the entire ecosystem — biotechs, foundations and advocacy groups — aligns around a shared purpose.

Bringing therapies to life with collaborations that count

At Genezen, collaboration is central to how we support innovators advancing life-changing therapies. This hub shares the stories behind those partnerships, highlighting what’s possible when trust, transparency and flexibility guide the work.

What collaboration means at Genezen

For us, collaboration means showing up with curiosity, accountability and a genuine investment in your success. We work alongside you as an extension of your team, adapting to change and making decisions with the patient in mind.

It’s a partnership built on shared goals, open communication and the understanding that every program is unique.

Real partnerships. Real progress.

Every collaboration tells a different story. From early development challenges to scaling for the clinic and beyond, these case studies highlight how we partner with biotechs, rare disease foundations, industry networks, and patient advocacy groups to solve complex problems and advance programs.

What do our partners say?

These perspectives reflect what collaboration looks like when it’s built on trust and mutual respect.

The Grays are determined, even after the loss of their daughter Charlotte to this extraordinarily challenging disease. They haven’t given up on finding a treatment for their other daughter, Gwennie, and others impacted by Batten disease.
Tiffany Sepp
CEO
Vanguard Clinical, Inc.
Their proficiency, responsiveness, and collaborative spirit have been crucial in driving this initiative forward, fostering renewed hope for children suffering from CLN6 Batten disease.
Kristen Gray
Founder and Director
The Charlotte & Gwenyth Gray Foundation to Cure Batten Disease
Genezen’s demonstrated technical capabilities make them an ideal partner to support the commercial development and advancement of our pipeline.
Michael Kelly
Senior Vice President
Chemistry, Manufacturing and Controls of Atsena Therapeutics
We are thrilled to partner with Genezen. Their experienced, dynamic team and state-of-the-art facilities make them a perfect match to turn our groundbreaking science into real therapies for patients.
Peter Weijmarshausen
Co-founder and CEO
Humane Genomics

Resources, insights and perspectives on partnership

True collaboration goes beyond execution to shape how challenges are approached and how decisions are made. Our leaders share insights into building meaningful partnerships in cell and gene therapy development and explain why moving beyond transactional models is essential in an increasingly complex landscape.

Discover how collaboration can be a strategic advantage.

Mission, vision and values

Our shared CURES values serve as a North Star for how we operate.

  • Committed to scientific excellence
  • Urgency in action for patients
  • Resilience and grit in operations
  • Execute with excellence and integrity
  • Solutions-driven for our partners
Find out more >

Let’s build a collaboration that counts

If you’re looking for a partner who values transparency, flexibility and shared purpose, we’d love to start the conversation.

Connect with us >